DOJ Reclassifies FDA-Approved Marijuana to Schedule III, Moves to Broaden Federal Rescheduling
TL;DR Summary
Following President Trump’s December 2025 executive order, the Justice Department and DEA placed FDA-approved marijuana products and state-licensed medicinal marijuana in Schedule III under the Controlled Substances Act and announced an expedited administrative hearing beginning June 29, 2026 to consider broader rescheduling from Schedule I to Schedule III, with procedural updates to speed rulemaking while maintaining federal controls.
- Office of Public Affairs | Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls Department of Justice (.gov)
- Trump Live Updates: DOJ Reclassifies Medical Marijuana, Navy Secretary Is Fired and More News The New York Times
- Trump reclassifies state-licensed medical marijuana as a less-dangerous drug KFOX
- Trump administration moves to reclassify cannabis in major shift that could expand research CNBC
- US set to move to reclassify marijuana as early as Wednesday, Axios reports Yahoo
Reading Insights
Total Reads
0
Unique Readers
22
Time Saved
2 min
vs 3 min read
Condensed
88%
479 → 58 words
Want the full story? Read the original article
Read on Department of Justice (.gov)